Testing effectiveness (Phase 2)UnknownNCT05392686What this trial is testingPD1 and PARP for Maintenance Therapy in NSLLCWho this might be right forLung Cancer Tianjin Medical University Cancer Institute and Hospital 52
Large-scale testing (Phase 3)Active Not RecruitingNCT04750226What this trial is testingStudy To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseWho this might be right forParkinson's Disease (PD) AbbVie 118
Large-scale testing (Phase 3)Study completedNCT04924062What this trial is testingPembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension StudyWho this might be right forBiliary Tract Carcinoma Merck Sharp & Dohme LLC 158
Large-scale testing (Phase 3)Looking for participantsNCT06312176What this trial is testingSacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Who this might be right forBreast Neoplasms Merck Sharp & Dohme LLC 1,200
Not applicableStudy completedNCT07143006What this trial is testingApplication of Smart Electric Vehicles in Analyzing Gait Abnormalities in Patients With Neurodegenerative DiseasesWho this might be right forParkinson DiseaseDementia Taipei Medical University Shuang Ho Hospital 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05173987What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)Who this might be right forEndometrial Neoplasms Merck Sharp & Dohme LLC 280
Large-scale testing (Phase 3)Study completedNCT00244387What this trial is testingRotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on LevodopaWho this might be right forParkinson Disease, Idiopathic UCB Pharma 506
Testing effectiveness (Phase 2)Study completedNCT02853344What this trial is testingStudy of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 275
Not applicableLooking for participantsNCT06965374What this trial is testingReal-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson DiseaseWho this might be right forParkinson Disease AbbVie 270
Large-scale testing (Phase 3)Study completedNCT03933449What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension StudyWho this might be right forEsophageal CarcinomaEsophagogastric Junction Carcinoma Merck Sharp & Dohme LLC 123
Not applicableStudy completedNCT02263885What this trial is testingExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's DiseaseWho this might be right forParkinson's Disease InSightec 20
Large-scale testing (Phase 3)Study completedNCT04889118What this trial is testingSafety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension StudyWho this might be right forMalignant Melanoma Merck Sharp & Dohme LLC 131
Not applicableStudy completedNCT02246374What this trial is testingExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's DiseaseWho this might be right forParkinson's Disease InSightec 7
Not applicableUnknownNCT05355480What this trial is testingHandwriting Analysis in Movement DisordersWho this might be right forMovement DisordersParkinson DiseaseWriting Disorder Neuromed IRCCS 40
Early research (Phase 1)Looking for participantsNCT05142189What this trial is testingClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer BioNTech SE 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT04995523What this trial is testingAZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCWho this might be right forNon-Small-Cell Lung Carcinoma AstraZeneca 212
Not applicableUnknownNCT03406754What this trial is testingMulti-disciplinary Rehabilitation Program for Advanced Parkinson's Patients in the CommunityWho this might be right forParkinson's Disease Tel-Aviv Sourasky Medical Center 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06817200What this trial is testingThe Effect of Amantadine as add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled TrialWho this might be right forParkinson Disease (PD) University Hospital, Toulouse 132
Early research (Phase 1)Study completedNCT00292227What this trial is testingCardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's DiseaseWho this might be right forParkinson's Disease UCB Pharma 130
Not applicableStudy completedNCT05394688What this trial is testingDirectional Deep Brain Stimulation With Patients With Advanced Parkinson's DiseaseWho this might be right forParkinson Disease Hospital District of Helsinki and Uusimaa 20